0845 330 7556
Research, development and marketing of innovative products
including muskuloskeletal and ophthalmology.
TRB Chemedica (UK) Ltd markets the rheumatology and ophthalmology product ranges in the UK and Ireland.
OSTENIL® is a solution containing sodium hyaluronate used to relieve joint pain.
OSTENIL® TENDON is used to reduce pain and improve mobility in tendinopathy.
VISCOSEAL® is a synovial fluid replacement designed to aid recovery after arthroscopy.
VISMED® contains sodium hyaluronate and is ideal for relief from dry eye.
REMOGEN® OMEGA contains Omega-3 and is intended for ocular surface damage due to blepharitis, dry eye and surgery.
VISIOL® is a unique viscoelastic solution used during cataract surgery.
Announcement of Promotion to Business Manager. read more
With the help of Football 4 Football we have produced 3 brand-new videos on the positive effect OSTENIL® injections have had on the lives of professional football players.. read more
We have recently added another payment option: Direct Debit.. read more
. read more
TRB Chemedica (UK) Ltd has been made aware of a number of unauthorised internet-based drug and medical device sales at discount prices.... read more
GB Swans, the Great Britain Women's Australian Rules Football Team, have won the European Championship in London on Saturday, 20th August 2016.. read more
Comparison of peritendinous hyaluronan injections versus extracorporeal shock wave therapy in the treatment of painful Achilles tendinopathy: A randomized clinical efficacy and safety study.. read more
We now have a new facility on our OSTENIL® website to place orders for OSTENIL® products direct from us.. read more
We are currently recruiting four Graduate Sales Representatives in the South of England.. read more
TRB Chemedia donates OSTENIL PLUS syringes to help in free treatment programme for osteoarthritis in Ghana.. read more
Study concludes Ostenil Plus "as effective" as high molecular weight hyaluronan "but cheaper".. read more
A new video on VISCOSEAL Syringe is now available to view.. read more
We would like to let our customers know that REMOGEN Omega, the eye drop containing Omega-3 fatty acids to aid the recovery of the lipid layer of the tear film, is once again available from our partners, Butterflies Eyecare. . read more
In a Twitter conversation this weekend, former Premiership footballer, Don Hutchison, recommended OSTENIL as a "god send" and as "#injectionofoil".. read more
We would like to make our esteemed customers and readers aware of a few new studies that have recently come to our attention.. read more
This study shows that " hyaluronate injection is a preferable alternative to steroid injections for the treatment of tennis elbow." . read more
The following two Review Articles on the effectiveness of sodium hyaluronate treatment of both rotator cuff tears and tendon lesions have just come to our attention: . read more
A report on how people suffering with symptomatic Osteoarthritis (OA) of the knee may still be able to remain active in sport has just been published in the Clinical Journal of Sport Medicine. . read more
Efficacy and safety of hyaluronic acid in the management of osteoarthritis: Evidence from real-life setting trials and surveys. read more
Professor Christophe Baudouin et al. recently published an interesting update on DED: "Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction".. read more
A new study shows that Hyaluronic Acid injections delay Total Knee Replacements by a significant amount of time.. read more
A new study has just been published entitled "Effect of Sodium Hyaluronate on Recovery after Arthroscopic Knee Surgery" (S Anand et al.).. read more
A new study has been published comparing VISMED® MULTI with 2 other lubricant eye drops on the corneal healing process in an ex vivo model.. read more
Two new papers on viscosupplementation have been published in recent weeks. read more
A new study shows OSTENIL® PLUS to be non-inferior to cross-linked HA injectable.. read more
TRB Chemedica (UK) Ltd
based at Lymedale Business Park, Newcastle-under-
Lyme. The company was established in January 2002
as the British subsidiary of the Swiss healthcare group,
TRB Chemedica International SA
TRB Chemedica (UK) Ltd is responsible for marketing the
rheumatology and ophthalmology product ranges in
the UK and Ireland.
In February of 2011 TRB Chemedica (UK) Ltd achieved
ISO 9001 accreditation. This underlines the company's
commitment to its customers and to its focus on quality.
It also demonstrates that the company provides a high
quality service throughout the business.